Velocity Pharma LLC is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for rare and complex diseases. They generate revenue through the research, development, and sale of proprietary drugs and treatments, often collaborating with healthcare providers and research institutions. Founded in 2008, the company has a history of significant breakthroughs, including the approval of several first-in-class medications. Their commitment to addressing unmet medical needs has positioned them as a leader in the biotech industry.